AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STRATA Skin Sciences, Inc. Director's Dealing 2023

Apr 5, 2023

35146_dirs_2023-04-04_a54142d3-1bd7-4b52-8ec2-98a847454e9d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2023-04-03

Reporting Person: Moccia Robert Joseph (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-03	Employee Stock Option	$1.06	A	75000	Acquired	2033-04-03	Common Stock (75000)	Direct
2023-04-03	Employee Stock Option	$1.06	A	75000	Acquired	2033-04-03	Common Stock (75000)	Direct

Footnotes

F1: Options shall vest in four equal installments over a four year period on each of the following dates: March 30, 2023, March 30, 2024, March 30, 2025 and on March 30, 2026.

F2: Vesting of these options depends upon the Company's achieving a targeted stock price as set on the date of grant by the Compensation Committee. The target must be achieved by December 31, 2023 or the options lapse.